Home / Science / Can Medicine Now Target Aging Itself?

Can Medicine Now Target Aging Itself?

Summary

  • Scientists explore targeting biological aging processes, not just age-related diseases.
  • Biomarkers of aging could predict health outcomes and act as trial surrogates.
  • Longevity clinics are emerging, with some regions establishing regulatory frameworks.

Medicine is on the cusp of targeting aging itself, moving beyond merely treating age-related diseases. Researchers are exploring ways to measure and influence the biological changes that occur over time, with the ultimate goal of increasing both lifespan and health span. This approach suggests intervening in aging processes before they lead to conditions like heart disease or cancer.

While animal studies have demonstrated that interventions can slow aging and extend life, human clinical trials are still in their nascent stages. Scientists are developing sophisticated biological markers, such as epigenetic changes and multi-omic data, to track aging and assess the impact of potential treatments. The challenge lies in connecting these biomarkers to long-term health benefits.

As this science evolves, specialized longevity clinics are emerging globally. For instance, Abu Dhabi has pioneered a regulatory framework for such centers, establishing a formal category for 'Healthy Longevity Medicine.' However, experts also note that foundational elements like good sleep, exercise, diet, and community engagement remain crucial for extending healthy years, often accessible without advanced medical interventions.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

Read more news on

Property Code: 5571